OLN:NYSE
Olin Corp
$15.66
arrow_upward
+0.77%(+0.12) 1D
$15.75
arrow_upward
+0.57% (+0.090)bedtimeAfter hours
Closed: Oct 23, 4:00:03 PM GMT-4 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for OLN...
Open
$15.55
High
$15.88
Low
$15.26
Mkt. cap
1.78B
Avg. vol.
3.98M
Volume
4.57M
Dividend
5.11%
Quarterly dividend
$0.20
Ex-dividend date
Aug 27, 2026
52-wk high
$30.46
52-wk low
$14.64
EPS
-$1.74
Beta
1.23
Shares outstanding
113.98M
No. of employees
8K
Open
$15.55
High
$15.88
Low
$15.26
Mkt. cap
1.78B
Avg. vol.
3.98M
Volume
4.57M
Dividend
5.11%
Quarterly dividend
$0.20
Ex-dividend date
Aug 27, 2026
52-wk high
$30.46
52-wk low
$14.64
EPS
-$1.74
Beta
1.23
Shares outstanding
113.98M
No. of employees
8K
News stories
From web sources and news partners
Profile
Olin Corporation is an American manufacturer of ammunition, chlorine, and sodium hydroxide. The company traces its roots to two companies, both founded in 1892: Franklin W. Olin's Equitable Powder Company and the Mathieson Alkali Works. Wikipedia
About Olin Corp
CEOScott M. Sutton
Employees7.85K
Founded1892
HeadquartersClayton, Missouri, United States
SectorCommodity chemical
Websiteolin.com
Analyst ratings
Based on 13 analysts giving stock ratings to OLN in the past 3 months
Hold
Buy
1
Hold
11
Sell
1
12-month forecast
Based on 13 Wall Street analysts offering 12 month price targets for OLN in the last 3 months.
Highest
Current $15.66
$26.00 (+66.03%)
Average
$18.69 (+19.35%)
Lowest
$15.00 (-4.21%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Pete Osterland Truist Financial | Hold | Maintained | $15.00 | -4.2% | 10/20/2026 |
Abigail Eberts Wells Fargo | Hold | Maintained | $16.00 | +2.2% | 10/15/2026 |
Arun Viswanathan RBC Capital | Hold | Maintained | $16.00 | +2.2% | 10/13/2026 |
Michael Leithead Barclays | Hold | Initiated | $18.00 | +14.9% | 10/12/2026 |
Aleksey Yefremov Barclays | Hold | Initiated | $18.00 | +14.9% | 10/12/2026 |
David Begleiter Deutsche Bank | Hold | Maintained | $18.00 | +14.9% | 10/06/2026 |
Matthew DeYoe Bank of America Securities | Sell | Maintained | $16.00 | +2.2% | 10/05/2026 |
Joshua Spector UBS | Hold | Maintained | $18.00 | +14.9% | 10/05/2026 |
Duffy Fischer Goldman Sachs | Hold | Reiterated | $18.00 | +14.9% | 09/30/2026 |
Patrick Cunningham Citi | Hold | Maintained | $17.00 | +8.6% | 10/01/2026 |
John Roberts CFA Mizuho Securities | Hold | Maintained | $21.00 | +34.1% | 09/23/2026 |
Unknown Analyst KeyBanc | Buy | Initiated | $26.00 | +66% | 09/11/2026 |
Salvator Tiano KeyBanc | Buy | Initiated | $26.00 | +66% | 09/11/2026 |
Jeffrey Zekauskas J.P. Morgan | Hold | Maintained | $19.00 | +21.3% | 08/04/2026 |
Michael Sison Wells Fargo | Hold | Downgraded | $20.00 | +27.7% | 08/03/2026 |
Bhavesh Lodaya BMO Capital | Hold | Maintained | $25.00 | +59.6% | 07/31/2026 |
Edlain Rodriguez Mizuho Securities | Hold | Maintained | $24.00 | +53.3% | 07/31/2026 |
Hassan Ahmed Alembic Global | Buy | Maintained | $28.00 | +78.8% | 06/24/2026 |
Vincent Andrews Morgan Stanley | Sell | Maintained | $22.00 | +40.5% | 05/11/2026 |
Michael Roxland Truist Financial | Hold | Maintained | $26.00 | +66% | 05/11/2026 |
Unknown Analyst Goldman Sachs | Hold | Maintained | $22.00 | +40.5% | 05/08/2026 |
Unknown Analyst J.P. Morgan | Hold | Maintained | $20.00 | +27.7% | 02/03/2026 |
Next call in 6 days
Fri, Oct 30, 4:00 PM
Fiscal period
Q3 2026
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
- / $0.16
Revenue / Est. (USD)
- / 1.84B
Fiscal Q3 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 1.71B | 1.67B | 1.58B | 1.74B |
Cost of goods sold | 1.53B | 1.63B | 1.51B | 1.57B |
Cost of revenue | 1.53B | 1.63B | 1.51B | 1.57B |
Research and development expenses | - | - | - | - |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 93.20M | 88.90M | 141.50M | 100.10M |
Operating expense | 92.80M | 88.60M | 141.50M | 100.00M |
Total operating expenses | 1.62B | 1.72B | 1.65B | 1.67B |
Operating income | 90.60M | -58.30M | -65.70M | 70.20M |
Other non operating income | - | - | - | - |
EBT including unusual items | 41.50M | -197.90M | -118.30M | 3.80M |
EBT excluding unusual items | 44.40M | -104.80M | -109.20M | 24.90M |
Income tax expense | -2.20M | -54.70M | -35.30M | 17.10M |
Effective tax rate | -5.30% | 27.64% | 29.84% | 450.00% |
Other operating expenses | -400.00K | -300.00K | - | -100.00K |
Net income | 42.80M | -143.40M | -83.00M | -13.30M |
Net profit margin | 2.50% | -8.61% | -5.24% | -0.76% |
Earnings per share | 0.39 | -0.64 | -0.33 | 0.07 |
Interest and investment income | 1.60M | 400.00K | 1.10M | - |
Interest expense | -46.80M | -46.20M | -43.20M | -44.30M |
Net interest expenses | -45.20M | -45.80M | -42.10M | -44.30M |
Depreciation and amortization charges | - | - | - | - |
EBITDA | 224.40M | 67.40M | 51.50M | 192.30M |
Gain or loss from assets sale | - | - | - | - |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1
Upcoming events